Sfoglia per Autore KORDASTI, Shahram Yaser
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
2007-01-01 Kordasti, Shahram Y; Ingram, Wendy; Hayden, Janet; Darling, David; Barber, Linda; Afzali, Behdad; Lombardi, Giovanna; Wlodarski, Marcin W; Maciejewski, Jaroslaw P; Farzaneh, Farzin; Mufti, Ghulam J
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)
2007-01-01 Kordasti, S. Y.; Ingram, W.; Hayden, J.; Darling, D.; Barber, L.; Afzali, B.; Lombardi, G.; Wlodarski, M. W.; Maciejewski, J. P.; Farzaneh, F.; Mufti, G. J.
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab
2009-01-01 Matthews, K.; Lim, Z.; Afzali, B.; Pearce, L.; Abdallah, A.; Kordasti, S.; Pagliuca, A.; Lombardi, G.; Madrigal, J. A.; Mufti, G. J.; Barber, L. D.
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study
2009-01-01 Ingram, W.; Chan, L.; Guven, H.; Darling, D.; Kordasti, S.; Hardwick, N.; Barber, L.; Mufti, G. J.; Farzaneh, F.
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome
2009-01-01 Kordasti, S. Y.; Afzali, B.; Lim, Z.; Ingram, W.; Hayden, J.; Barber, L.; Matthews, K.; Chelliah, R.; Guinn, B.; Lombardi, G.; Farzaneh, F.; Mufti, G. J.
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures
2009-01-01 Ingram, W.; Kordasti, S.; Chan, L.; Barber, L. D.; Tye, G. J.; Hardwick, N.; Mufti, G. J.; Farzaneh, F.
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party
2012-01-01 Marsh, J. C.; Bacigalupo, A.; Schrezenmeier, H.; Tichelli, A.; Risitano, A. M.; Passweg, J. R.; Killick, S. B.; Warren, A. J.; Foukaneli, T.; Aljurf, M.; Al-Zahrani, H. A.; Schafhausen, P.; Roth, A.; Franzke, A.; Brummendorf, T. H.; Dufour, C.; Oneto, R.; Sedgwick, P.; Barrois, A.; Kordasti, S.; Elebute, M. O.; Mufti, G. J.; Socie, G.
Functional characterization of CD4+ T cells in aplastic anemia
2012-01-01 Kordasti, S.; Marsh, J.; Al-Khan, S.; Jiang, J.; Smith, A.; Mohamedali, A.; Abellan, P. P.; Veen, C.; Costantini, B.; Kulasekararaj, A. G.; Benson-Quarm, N.; Seidl, T.; Mian, S. A.; Farzaneh, F.; Mufti, G. J.
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
2012-01-01 Westers, T. M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J. A.; Della Porta, M. G.; Drager, A. M.; Feuillard, J.; Font, P.; Germing, U.; Haase, D.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Ogata, K.; Orfao, A.; Porwit, A.; Psarra, K.; Richards, S. J.; Subira, D.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; De Witte, T. M.; Wells, D. A.; Zettl, F.; Bene, M. C.; Van De Loosdrecht, A. A.
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome
2013-01-01 Costantini, B.; Kordasti, S. Y.; Kulasekararaj, A. G.; Jiang, J.; Seidl, T.; Abellan, P. P.; Mohamedali, A.; Thomas, N. S. B.; Farzaneh, F.; Mufti, G. J.
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation
2013-01-01 Afzali, B.; Edozie, F. C.; Fazekasova, H.; Scotta, C.; Mitchell, P. J.; Canavan, J. B.; Kordasti, S. Y.; Chana, P. S.; Ellis, R.; Lord, G. M.; John, S.; Hilton, R.; Lechler, R. I.; Lombardi, G.
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner
2013-01-01 Afzali, B.; Mitchell, P. J.; Edozie, F. C.; Povoleri, G. A. M.; Dowson, S. E.; Demandt, L.; Walter, G.; Canavan, J. B.; Scotta, C.; Menon, B.; Chana, P. S.; Khamri, W.; Kordasti, S. Y.; Heck, S.; Grimbacher, B.; Tree, T.; Cope, A. P.; Taams, L. S.; Lechler, R. I.; John, S.; Lombardi, G.
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group
2013-01-01 Van De Loosdrecht, A. A.; Ireland, R.; Kern, W.; Della Porta, M. G.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Bowen, D. T.; Burbury, K.; Eidenschink, L.; Cazzola, M.; Chu, S. S. C.; Cullen, M.; Cutler, J. A.; Drager, A. M.; Feuillard, J.; Fenaux, P.; Font, P.; Germing, U.; Haase, D.; Hellstrom-Lindberg, E.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Nikolova, V.; Ogata, K.; Oelschlaegel, U.; Orfao, A.; Ossenkoppele, G. J.; Porwit, A.; Platzbecker, U.; Preijers, F.; Psarra, K.; Richards, S. J.; Subira, D.; Seymour, J. F.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; Wells, D. A.; De Witte, T. M.; Zettl, F.; Bene, M. C.; Westers, T. M.
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy
2013-01-01 Kerkhoff, N.; Bontkes, H. J.; Westers, T. M.; De Gruijl, T. D.; Kordasti, S.; Van De Loosdrecht, A. A.
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role
2014-01-01 Bart-Smith, E. E.; Kordasti, S.; Kulasekararaj, A. G.; Richardson, D.; Mufti, G. J.; Marsh, J. C. W.
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome
2015-01-01 Kulasekararaj, A. G.; Kordasti, S.; Basu, T.; Salisbury, J. R.; Mufti, G. J.; du Vivier, A. W. P.
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells
2015-01-01 Keohane, C.; Kordasti, S.; Seidl, T.; Perez Abellan, P.; Thomas, N. S. B.; Harrison, C. N.; Mclornan, D. P.; Mufti, G. J.
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
2016-01-01 Kordasti, S.; Costantini, B.; Seidl, T.; Abellan, P. P.; Llordella, M. M.; Mclornan, D.; Diggins, K. E.; Kulasekararaj, A.; Benfatto, C.; Feng, X.; Smith, A.; Mian, S. A.; Melchiotti, R.; De Rinaldis, E.; Ellis, R.; Petrov, N.; Povoleri, G. A. M.; Chung, S. S.; Thomas, N. S. B.; Farzaneh, F.; Irish, J. M.; Heck, S.; Young, N. S.; Marsh, J. C. W.; Mufti, G. J.
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
2016-01-01 Kittang, A. O.; Kordasti, S.; Sand, K. E.; Costantini, B.; Kramer, A. M.; Perezabellan, P.; Seidl, T.; Rye, K. P.; Hagen, K. M.; Kulasekararaj, A.; Bruserud, O.; Mufti, G. J.
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation
2016-01-01 Ceesay, M. M.; Kordasti, S.; Rufaie, E.; Lea, N.; Smith, M.; Wade, J.; Douiri, A.; Mufti, G. J.; Pagliuca, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) | 1-gen-2007 | Kordasti, Shahram Y; Ingram, Wendy; Hayden, Janet; Darling, David; Barber, Linda; Afzali, Behdad; Lombardi, Giovanna; Wlodarski, Marcin W; Maciejewski, Jaroslaw P; Farzaneh, Farzin; Mufti, Ghulam J | |
| CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) | 1-gen-2007 | Kordasti, S. Y.; Ingram, W.; Hayden, J.; Darling, D.; Barber, L.; Afzali, B.; Lombardi, G.; Wlodarski, M. W.; Maciejewski, J. P.; Farzaneh, F.; Mufti, G. J. | |
| Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab | 1-gen-2009 | Matthews, K.; Lim, Z.; Afzali, B.; Pearce, L.; Abdallah, A.; Kordasti, S.; Pagliuca, A.; Lombardi, G.; Madrigal, J. A.; Mufti, G. J.; Barber, L. D. | |
| Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study | 1-gen-2009 | Ingram, W.; Chan, L.; Guven, H.; Darling, D.; Kordasti, S.; Hardwick, N.; Barber, L.; Mufti, G. J.; Farzaneh, F. | |
| IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome | 1-gen-2009 | Kordasti, S. Y.; Afzali, B.; Lim, Z.; Ingram, W.; Hayden, J.; Barber, L.; Matthews, K.; Chelliah, R.; Guinn, B.; Lombardi, G.; Farzaneh, F.; Mufti, G. J. | |
| Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures | 1-gen-2009 | Ingram, W.; Kordasti, S.; Chan, L.; Barber, L. D.; Tye, G. J.; Hardwick, N.; Mufti, G. J.; Farzaneh, F. | |
| Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party | 1-gen-2012 | Marsh, J. C.; Bacigalupo, A.; Schrezenmeier, H.; Tichelli, A.; Risitano, A. M.; Passweg, J. R.; Killick, S. B.; Warren, A. J.; Foukaneli, T.; Aljurf, M.; Al-Zahrani, H. A.; Schafhausen, P.; Roth, A.; Franzke, A.; Brummendorf, T. H.; Dufour, C.; Oneto, R.; Sedgwick, P.; Barrois, A.; Kordasti, S.; Elebute, M. O.; Mufti, G. J.; Socie, G. | |
| Functional characterization of CD4+ T cells in aplastic anemia | 1-gen-2012 | Kordasti, S.; Marsh, J.; Al-Khan, S.; Jiang, J.; Smith, A.; Mohamedali, A.; Abellan, P. P.; Veen, C.; Costantini, B.; Kulasekararaj, A. G.; Benson-Quarm, N.; Seidl, T.; Mian, S. A.; Farzaneh, F.; Mufti, G. J. | |
| Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group | 1-gen-2012 | Westers, T. M.; Ireland, R.; Kern, W.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Burbury, K.; Cullen, M.; Cutler, J. A.; Della Porta, M. G.; Drager, A. M.; Feuillard, J.; Font, P.; Germing, U.; Haase, D.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Ogata, K.; Orfao, A.; Porwit, A.; Psarra, K.; Richards, S. J.; Subira, D.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; De Witte, T. M.; Wells, D. A.; Zettl, F.; Bene, M. C.; Van De Loosdrecht, A. A. | |
| The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome | 1-gen-2013 | Costantini, B.; Kordasti, S. Y.; Kulasekararaj, A. G.; Jiang, J.; Seidl, T.; Abellan, P. P.; Mohamedali, A.; Thomas, N. S. B.; Farzaneh, F.; Mufti, G. J. | |
| Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation | 1-gen-2013 | Afzali, B.; Edozie, F. C.; Fazekasova, H.; Scotta, C.; Mitchell, P. J.; Canavan, J. B.; Kordasti, S. Y.; Chana, P. S.; Ellis, R.; Lord, G. M.; John, S.; Hilton, R.; Lechler, R. I.; Lombardi, G. | |
| CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner | 1-gen-2013 | Afzali, B.; Mitchell, P. J.; Edozie, F. C.; Povoleri, G. A. M.; Dowson, S. E.; Demandt, L.; Walter, G.; Canavan, J. B.; Scotta, C.; Menon, B.; Chana, P. S.; Khamri, W.; Kordasti, S. Y.; Heck, S.; Grimbacher, B.; Tree, T.; Cope, A. P.; Taams, L. S.; Lechler, R. I.; John, S.; Lombardi, G. | |
| Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group | 1-gen-2013 | Van De Loosdrecht, A. A.; Ireland, R.; Kern, W.; Della Porta, M. G.; Alhan, C.; Balleisen, J. S.; Bettelheim, P.; Bowen, D. T.; Burbury, K.; Eidenschink, L.; Cazzola, M.; Chu, S. S. C.; Cullen, M.; Cutler, J. A.; Drager, A. M.; Feuillard, J.; Fenaux, P.; Font, P.; Germing, U.; Haase, D.; Hellstrom-Lindberg, E.; Johansson, U.; Kordasti, S.; Loken, M. R.; Malcovati, L.; Te Marvelde, J. G.; Matarraz, S.; Milne, T.; Moshaver, B.; Mufti, G. J.; Nikolova, V.; Ogata, K.; Oelschlaegel, U.; Orfao, A.; Ossenkoppele, G. J.; Porwit, A.; Platzbecker, U.; Preijers, F.; Psarra, K.; Richards, S. J.; Subira, D.; Seymour, J. F.; Tindell, V.; Vallespi, T.; Valent, P.; Van Der Velden, V. H. J.; Wells, D. A.; De Witte, T. M.; Zettl, F.; Bene, M. C.; Westers, T. M. | |
| Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy | 1-gen-2013 | Kerkhoff, N.; Bontkes, H. J.; Westers, T. M.; De Gruijl, T. D.; Kordasti, S.; Van De Loosdrecht, A. A. | |
| Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role | 1-gen-2014 | Bart-Smith, E. E.; Kordasti, S.; Kulasekararaj, A. G.; Richardson, D.; Mufti, G. J.; Marsh, J. C. W. | |
| Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome | 1-gen-2015 | Kulasekararaj, A. G.; Kordasti, S.; Basu, T.; Salisbury, J. R.; Mufti, G. J.; du Vivier, A. W. P. | |
| JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells | 1-gen-2015 | Keohane, C.; Kordasti, S.; Seidl, T.; Perez Abellan, P.; Thomas, N. S. B.; Harrison, C. N.; Mclornan, D. P.; Mufti, G. J. | |
| Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment | 1-gen-2016 | Kordasti, S.; Costantini, B.; Seidl, T.; Abellan, P. P.; Llordella, M. M.; Mclornan, D.; Diggins, K. E.; Kulasekararaj, A.; Benfatto, C.; Feng, X.; Smith, A.; Mian, S. A.; Melchiotti, R.; De Rinaldis, E.; Ellis, R.; Petrov, N.; Povoleri, G. A. M.; Chung, S. S.; Thomas, N. S. B.; Farzaneh, F.; Irish, J. M.; Heck, S.; Young, N. S.; Marsh, J. C. W.; Mufti, G. J. | |
| Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome | 1-gen-2016 | Kittang, A. O.; Kordasti, S.; Sand, K. E.; Costantini, B.; Kramer, A. M.; Perezabellan, P.; Seidl, T.; Rye, K. P.; Hagen, K. M.; Kulasekararaj, A.; Bruserud, O.; Mufti, G. J. | |
| Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation | 1-gen-2016 | Ceesay, M. M.; Kordasti, S.; Rufaie, E.; Lea, N.; Smith, M.; Wade, J.; Douiri, A.; Mufti, G. J.; Pagliuca, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile